Phanstiel S. Louise

SEC source: 0002064832-26-000274 · form4.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Phanstiel Trust u/a/d 2/5/02

Disclosed balance after: 300,461

F1 · price: Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $8.49 to $8.865 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0002064832-26-000234 · form4.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,952

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2027 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001471518-26-000004 · wk-form4_1780691109.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,652

F1 · shares: Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 3

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,951

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.79, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 2

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,951

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $5.01, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,544

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.725 to $4.75, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002064832-25-000087 · form4.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Phanstiel Trust u/a/d 2/5/02

Disclosed balance after: 185,261

F1 · price: Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $3.015 to $3.15 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001062993-25-011826 · form4.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,505

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2026 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001628280-25-029975 · wk-form4_1749240296.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,444

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001104659-24-099788 · tm2424059-1_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by H.G. Phanstiel LP

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected for tax planning purposes.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.935 to $1.975 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3 · ownership.nature: Ms. Phanstiel is the Managing Member of H.G. Phanstiel LP. Ms. Phanstiel disclaims beneficial ownership of the securities held by H.G. Phanstiel LP except to the extent of her pecuniary interest therein.

SEC source: 0001104659-24-070859 · tm2417034-3_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,071

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2025 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001628280-24-027329 · wk-form4_1717793624.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,648

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001104659-23-073787 · tm2319416-4_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,177

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2024 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001471518-23-000004 · wk-form4_1685743243.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,953

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001104659-22-073492 · tm2219003-3_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,388

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001628280-22-016222 · wf-form4_165429161615332.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,802

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001471518-21-000002 · edgardoc.xml · derivative · entry 6

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2021-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001471518-21-000002 · edgardoc.xml · derivative · entry 5

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2021-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

SEC source: 0001471518-21-000002 · edgardoc.xml · nonDerivative · entry 3

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001471518-21-000002 · edgardoc.xml · nonDerivative · entry 2

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,646

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.49 to $35.50, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001471518-21-000002 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-21-004731 · primarydocument.xml · derivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,645

Underlying: Common Stock · 21,645 shares

Expires 2031-06-30

F1 · shares: These options were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors.

F2 · derivative.exercise_date: The option vests in full on the date of the Butterfly Network, Inc. 2022 Annual Stockholders meeting, subject to the Reporting Person's continued services on the Board of Directors on such date.

SEC source: 0000899243-21-022151 · doc4.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,527

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.

F2 · balance_after: The Reporting Person previously reported total beneficial ownership of 82,679 shares of common stock held directly and 5,000 shares of common stock held indirectly through The Phanstiel Trust. Except for the acquisition of 12,848 shares of common stock reported in this Form 4, the Reporting Person's total beneficial ownership of shares of common stock has not changed, but this Form 4 corrects the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.

SEC source: 0001104659-21-024565 · tm216719-22_4seq1.xml · nonDerivative · entry 2

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,157

F3 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on February 16, 2022, subject to Ms. Phanstiel's continued service through the applicable vesting date.

SEC source: 0001104659-21-024565 · tm216719-22_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by H.G. Phanstiel LP

Disclosed balance after: 60,049

F1 · price: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition Corp. ("Longview"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview ("Merger Sub"), and Butterfly Network, Inc., a Delaware corporation ("Butterfly"), pursuant to which Merger Sub merged with and into Butterfly, with Butterfly surviving as a wholly-owned subsidiary of Longview (which changed its name to "Butterfly Network, Inc.", the "Issuer"), these shares were received upon conversion of an aggregate principal amount of $592,221, plus accrued but unpaid interest, of Butterfly convertible notes, based on a conversion price of $10.00 per share.

F2 · ownership.nature: Ms. Phanstiel is the Managing Member of H.G. Phanstiel LP. Ms. Phanstiel disclaims beneficial ownership of the securities held by H.G. Phanstiel LP except to the extent of her pecuniary interest therein.

SEC source: 0001471518-20-000004 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,679

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

SEC source: 0001471518-20-000002 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,790

SEC source: 0001471518-19-000007 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,790

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

SEC source: 0001471518-18-000002 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,103

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

SEC source: 0000904454-19-000231 · edgar.xml · derivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-06-11

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which the remaining unvested portion shall vest), beginning on 7/11/2018 and ending on 06/11/2019, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date.

SEC source: 0001471518-17-000002 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,743

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

SEC source: 0001104659-17-039556 · a4.xml · derivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-06-13

F1 · derivative.exercise_date: This option will vest in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017.

SEC source: 0001471518-16-000007 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.